Fondazione Serena Onlus- Centro Clinico NEMO

Milan, Lombardy 20162

0 studies enrolling now · 2 studies all time

What they study most

Duchenne Muscular Dystrophy (DMD), Facioscapulohumeral Muscular Dystrophy (FSHD)

Studies at this site

• Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) — Stopped early
• Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping — Running, not enrolling